Kwality [KPL] vs Sun Pharma Advanced [SPARC] Detailed Stock Comparison

Kwality Pharmaceuticals Ltd.

BSE
Loading...

Sun Pharma Advanced Research Company Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Kwality Pharmaceuticals Ltd. wins in 16 metrics, Sun Pharma Advanced Research Company Ltd. wins in 2 metrics, with 0 ties. Kwality Pharmaceuticals Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Kwality Pharmaceuticals Ltd. Sun Pharma Advanced Research Company Ltd. Better
P/E Ratio (TTM) 30.86 -13.65 Kwality Pharmaceuticals Ltd.
Price-to-Book Ratio 6.02 -13.55 Kwality Pharmaceuticals Ltd.
Debt-to-Equity Ratio 38.29 -1.21 Kwality Pharmaceuticals Ltd.
PEG Ratio 0.35 -11.15 Kwality Pharmaceuticals Ltd.
EV/EBITDA 17.28 -22.27 Kwality Pharmaceuticals Ltd.
Profit Margin (TTM) 12.25% -53.22% Kwality Pharmaceuticals Ltd.
Operating Margin (TTM) 20.79% -700.71% Kwality Pharmaceuticals Ltd.
EBITDA Margin (TTM) 20.79% N/A N/A
Return on Equity 15.19% 157.88% Sun Pharma Advanced Research Company Ltd.
Return on Assets (TTM) 8.91% -102.08% Kwality Pharmaceuticals Ltd.
Free Cash Flow (TTM) $277.15M $-3.71B Kwality Pharmaceuticals Ltd.
1-Year Return 159.49% 14.56% Kwality Pharmaceuticals Ltd.
Price-to-Sales Ratio (TTM) 3.78 87.98 Kwality Pharmaceuticals Ltd.
Enterprise Value $18.21B $50.87B Sun Pharma Advanced Research Company Ltd.
EV/Revenue Ratio 3.95 95.73 Kwality Pharmaceuticals Ltd.
Gross Profit Margin (TTM) 52.12% -59.53% Kwality Pharmaceuticals Ltd.
Revenue per Share (TTM) $444 $2 Kwality Pharmaceuticals Ltd.
Earnings per Share (Diluted) $54.54 $-8.25 Kwality Pharmaceuticals Ltd.
Beta (Stock Volatility) 0.13 0.19 Kwality Pharmaceuticals Ltd.

Kwality Pharmaceuticals Ltd. vs Sun Pharma Advanced Research Company Ltd. Stock Performance Analysis

Loading Price Chart...

KPL
SPARC

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Kwality Pharmaceuticals Ltd.2.22%6.00%38.44%51.48%148.86%103.68%
Sun Pharma Advanced Research Company Ltd.2.09%-13.30%46.20%62.20%26.84%51.26%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Kwality Pharmaceuticals Ltd.159.49%686.37%2,110.86%10,168.22%10,168.22%10,168.22%
Sun Pharma Advanced Research Company Ltd.14.56%13.10%-5.14%-23.02%148.11%-27.03%

Performance & Financial Health Analysis: Kwality Pharmaceuticals Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricKPLSPARC
Market Information
Market Cap i₹17.47B₹46.75B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i28,8972,401,062
90 Day Avg. Volume i30,3282,083,443
Last Close₹2,344.90₹208.50
52 Week Range₹828.80 - ₹2,389.70₹108.00 - ₹248.75
% from 52W High-1.87%-16.18%
All-Time High₹2,389.70 (Jun 01, 2026)₹875.00 (Apr 24, 2006)
% from All-Time High-1.87%-76.17%
Growth Metrics
Quarterly Revenue Growth0.46%-0.43%
Quarterly Earnings Growth0.88%-0.43%
Financial Health
Profit Margin (TTM) i0.12%-0.53%
Operating Margin (TTM) i0.21%-7.01%
Return on Equity (TTM) i0.15%1.58%
Debt to Equity (MRQ) i38.29-1.21
Cash & Liquidity
Book Value per Share (MRQ)₹279.50₹-10.63
Cash per Share (MRQ)₹32.82₹0.03
Operating Cash Flow (TTM) i₹387.34M₹-3,484,287,000
Levered Free Cash Flow (TTM) i₹398.45M₹-3,425,094,000
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i₹0.00N/A

Valuation & Enterprise Metrics Analysis: Kwality Pharmaceuticals Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricKPL (Apr 24, 2026)SPARC (Apr 22, 2026)
Price Ratios
P/E Ratio (TTM) i30.86-13.65
Forward P/E iN/A2.60
PEG Ratio i0.35-11.15
Price to Sales (TTM) i3.7887.98
Price to Book (MRQ) i6.02-13.55
Market Capitalization
Market Capitalization i₹17.47B₹46.75B
Enterprise Value i₹18.21B₹50.87B
Enterprise Value Metrics
Enterprise to Revenue i3.9595.73
Enterprise to EBITDA i17.28-22.27
Risk & Other Metrics
Beta i0.130.19
Book Value per Share (MRQ) i₹279.50₹-10.63

Financial Statements Comparison: Kwality Pharmaceuticals Ltd. vs Sun Pharma Advanced Research Company Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricKPL (2025)SPARC (2025)
Revenue/Sales i3.70B717.66M
Cost of Goods Sold i1.87B1.10B
COGS % of Revenue i50.6%153.2%
Gross Profit i1.83B-381.94M
Gross Margin i49.4%-53.2%
Research & Development iN/AN/A
Operating Income (EBIT) i620.98M-3.34B
Operating Margin i16.8%-465.5%
EBITDA i822.79M-3.23B
EBITDA Margin i22.2%-450.0%
Pre-Tax Income i541.40M-3.43B
Pre-Tax Income % of Revenue i14.6%-477.6%
Income Tax i143.37M-2.72M
Income Tax % of Revenue i3.9%-0.4%
Net Income (Profit) i398.03M-3.43B
Profit Margin i10.8%-477.3%

Balance Sheet & Liquidity Metrics

MetricKPL (2025)SPARC (2025)
Cash & Equivalents i120.20M19.64M
Total Current Assets i2.84B261.97M
Total Current Assets % of Revenue i76.7%36.5%
Total Current Liabilities i1.70B3.74B
Total Current Liabilities % of Revenue i45.8%521.5%
Long-Term Debt i151.19M1.07B
Long-Term Debt % of Revenue i4.1%149.0%
Total Shareholders Equity i2.62B-2.17B
Retained Earnings i2.44B-23.22B
Retained Earnings % of Revenue i66.0%-3,235.0%
Property, Plant & Equipment i458.28M178.02M

Cash Flow Statement Comparison

MetricKPL (2025)SPARC (2025)
Operating Cash Flow i387.34M-3.48B
Operating Cash Flow % of Revenue i10.5%-485.5%
Capital Expenditures i-232.17M-97.45M
Free Cash Flow i277.15M-3.71B
FCF Margin i7.5%-516.4%
Debt Repayment i-133.57M-3.69B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricKPLSPARC
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i10.38M324.52M
Float Shares i2.30M91.32M
% Held by Insiders i103.85%72.96%
% Held by Institutions i0.00%2.56%
% Held by Public i-3.85%24.48%

Dividend Analysis & Yield Comparison: Kwality Pharmaceuticals Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricKPLSPARC
Last 12-Month Dividend i₹0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i₹0.00N/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends i₹0.00N/A
Ex-Dividend DateN/AN/A